Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Observational study of the safety of an ultra-rush sublingual immunotherapy regimen to treat rhinitis due to house dust mites.

Roger A, Justicia JL, Navarro LÁ, Eseverri JL, Ferrès J, Malet A, Alvà V.

Int Arch Allergy Immunol. 2011;154(1):69-75. doi: 10.1159/000319211. Epub 2010 Jul 27.

PMID:
20664280
2.

Safety and tolerability of ultra-rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma.

Gammeri E, Arena A, D'Anneo R, La Grutta S.

Allergol Immunopathol (Madr). 2005 Jul-Aug;33(4):221-3.

PMID:
16045861
3.

[Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].

Zhou L, Wang J, Chen Y, Luo R, Tao J, Nie M, Liu B, Li Y.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 Oct;26(20):913-6. Chinese.

PMID:
23272490
4.

Safety and tolerability of ultra-Rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma.

Gammeri E, Arena A, D'Anneo R, La Grutta S.

Allergol Immunopathol (Madr). 2005 May-Jun;33(3):142-4.

PMID:
15946626
5.

[Observation on the effect of the dust mite sublingual immunotherapy for allergic rhinitis].

Du X, Shu C, Xu G, Ma M, Song H.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 Apr;26(8):372-3. Chinese.

PMID:
22730824
6.

Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study.

Di Rienzo V, Marcucci F, Puccinelli P, Parmiani S, Frati F, Sensi L, Canonica GW, Passalacqua G.

Clin Exp Allergy. 2003 Feb;33(2):206-10.

PMID:
12580913
7.

Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children.

Yonekura S, Okamoto Y, Sakurai D, Horiguchi S, Hanazawa T, Nakano A, Kudou F, Nakamaru Y, Honda K, Hoshioka A, Shimojo N, Kohno Y.

Allergol Int. 2010 Dec;59(4):381-8. doi: 10.2332/allergolint.10-OA-0200. Epub 2010 Sep 25.

8.

Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice.

Ferrés J, Justicia JL, García MP, Muñoz-Tudurí M, Alvà V.

Allergol Immunopathol (Madr). 2011 May-Jun;39(3):122-7. doi: 10.1016/j.aller.2010.01.008. Epub 2010 May 31.

PMID:
20570032
9.

Safety, tolerability and clinical efficacy of ultra-rush sublingual immunotherapy among patients suffering from allergic rhinitis.

Balaji R, Parasuramalu BG, Chandregowda BV, Gangaboraiah.

Allergol Immunopathol (Madr). 2014 May-Jun;42(3):216-23. doi: 10.1016/j.aller.2012.12.005. Epub 2013 Mar 5.

PMID:
23481554
10.

Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.

Wang DH, Chen L, Cheng L, Li KN, Yuan H, Lu JH, Li H.

Laryngoscope. 2013 Jun;123(6):1334-40. doi: 10.1002/lary.23935. Epub 2013 Apr 24.

PMID:
23616386
11.

[Compliance and safety evaluation of subcutaneous versus sublingual immunotherapy in mite-sensitized patients with allergic rhinitis].

Zhu L, Lu JH, Xie Q, Wu YL, Zhu LP, Cheng L.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010 Jun;45(6):444-9. Chinese.

PMID:
21055319
12.

Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy.

Rodríguez-Pérez N, Ambriz-Moreno Mde J, Canonica GW, Penagos M.

Ann Allergy Asthma Immunol. 2008 Sep;101(3):304-10.

PMID:
18814454
13.
14.

Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.

Tonnel AB, Scherpereel A, Douay B, Mellin B, Leprince D, Goldstein N, Delecluse P, Andre C.

Allergy. 2004 May;59(5):491-7.

15.

Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.

Serrano P, Justicia JL, Sánchez C, Cimarra M, Fernández-Távora L, Orovitg A, Moreno C, Guerra F, Alvà V.

Ann Allergy Asthma Immunol. 2009 Mar;102(3):247-52. doi: 10.1016/S1081-1206(10)60088-9.

PMID:
19354072
16.

Children passive smoking jeopardises the efficacy of standard anti-allergic pharmacological therapy, while sublingual immunotherapy withstands.

Marogna M, Massolo A, Colombo F, Isella P, Bruno M, Falagiani P.

Allergol Immunopathol (Madr). 2011 Mar-Apr;39(2):60-7. doi: 10.1016/j.aller.2010.05.002. Epub 2011 Jan 7.

PMID:
21216083
17.

Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis.

Lee JE, Choi YS, Kim MS, Han DH, Rhee CS, Lee CH, Kim DY.

Ann Allergy Asthma Immunol. 2011 Jul;107(1):79-84. doi: 10.1016/j.anai.2011.03.012. Epub 2011 Apr 22.

PMID:
21704889
18.

Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis.

Zhang L, Wang C, Han D, Wang X, Zhao Y, Liu J.

Int Arch Allergy Immunol. 2009;148(2):161-9. doi: 10.1159/000155747. Epub 2008 Sep 19.

PMID:
18802361
19.

[Rush immunotherapy of perennial allergic rhinitis].

Ito K.

Arerugi. 1989 Nov;38(11):1246-54. Japanese.

PMID:
2627159
20.

Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.

Tahamiler R, Saritzali G, Canakcioglu S.

Laryngoscope. 2007 Jun;117(6):965-9.

PMID:
17545861

Supplemental Content

Support Center